Company Filing History:
Years Active: 2017
Title: Jean Menager: Innovator in Alzheimer's Disease Treatment
Introduction
Jean Menager is a notable inventor based in Chilly Mazarin, France. He has made significant contributions to the field of neurodegenerative diseases, particularly in the treatment of Alzheimer's disease. His innovative work has led to the development of a unique patent that addresses critical therapeutic needs.
Latest Patents
Jean Menager holds a patent for an H3 receptor antagonist aimed at treating Alzheimer's disease. This patent, identified as 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide, relates to methods of using this compound in disease-modifying therapy for Alzheimer's disease, other tauopathies, and related neurodegenerative conditions. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Jean Menager is associated with Sanofi, a leading global healthcare company. His role at Sanofi has allowed him to focus on innovative solutions for complex health issues. His work is characterized by a dedication to improving patient outcomes through scientific research and development.
Collaborations
Throughout his career, Jean has collaborated with esteemed colleagues such as Pascal Barneoud and Veronique Blanchard-Bregeon. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of neurodegenerative diseases.
Conclusion
Jean Menager's contributions to the treatment of Alzheimer's disease through his innovative patent exemplify the impact of dedicated inventors in the medical field. His work continues to inspire advancements in therapeutic approaches for neurodegenerative conditions.